Approval

Cambridge biotech wins approval for highly controversial ALS drug - The Boston Globe

Cambridge biotech wins approval for highly controversial ALS drug – The Boston Globe

Since 1995, only two drugs have been approved to treat amyotrophic lateral sclerosis — also known as Lou Gehrig’s disease — and neither works very well. “This approval provides another important treatment option for ALS, a rare and life-threatening disease that currently has no cure,” said Dr. Billy Dunn, director of the Office of Neuroscience …

Cambridge biotech wins approval for highly controversial ALS drug – The Boston Globe Read More »

Approval of New Pediatric Medicine Residency Program Helps Improve Child and Family Care in Nevada |  University of Nevada, Reno

Approval of New Pediatric Medicine Residency Program Helps Improve Child and Family Care in Nevada | University of Nevada, Reno

The University of Nevada, Reno School of Medicine (UNR Med), and Renown Health are pleased to announce the accreditation of a new three-year pediatric residency program with the Accreditation Council for Higher Medical Education (ACGME). The inaugural cohort of pediatric residents will begin next summer, in July 2023. The new residency will help shape future …

Approval of New Pediatric Medicine Residency Program Helps Improve Child and Family Care in Nevada | University of Nevada, Reno Read More »